GeneCentric Diagnostics' Series B Round

GeneCentric Diagnostics raised a round of funding on January 06, 2017. Investors include Hatteras Venture Partners.

GeneCentric Diagnostics focuses on the development and commercialization of molecular diagnostic assays that enable oncologists and patients to make more informed, individualized treatment decisions.…

Articles about GeneCentric Diagnostics' Series B Round: